Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Luban

Showing results (41-50 of 152) with videos related to

Pageof 16
Sort By:
Molecular Biology of the Cell|February 10, 2004
HIV-1 Vpr induces defects in mitosis, cytokinesis, nuclear structure, and centrosomesFred Chang, Fabio Re, Sarah Sebastian, et al.
The Journal of Infectious Diseases|October 24, 2013
Overcoming current limitations in humanized mouse researchMichael A Brehm, Leonard D Shultz, Jeremy Luban, et al.
The Journal of Biological Chemistry|July 9, 2009
The double-stranded RNA binding domain of the vaccinia virus E3L protein inhibits both RNA- and DNA-induced activation of interferon betaJean-Baptiste Marq, Stéphane Hausmann, Jeremy Luban, et al.
Plos One|October 8, 2010
Cyclosporine A-sensitive, cyclophilin B-dependent endoplasmic reticulum-associated degradationRiccardo Bernasconi, Tatiana Soldà, Carmela Galli, et al.
The Journal of Clinical Investigation|September 17, 2005
TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ TregsBrygida Bisikirska, John Colgan, Jeremy Luban, et al.
Cell Reports|April 5, 2025
Molecular basis for the increased fusion activity of the Ebola virus glycoprotein epidemic variant A82V: Insights from simulations and experimentsNatasha D Durham, Aastha Jain, Angela Howard, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Regulation of Ebola GP conformation and membrane binding by the chemical environment of the late endosomeAastha Jain, Ramesh Govindan, Alex Berkman, et al.
Retrovirology|February 19, 2013
TNPO3 protects HIV-1 replication from CPSF6-mediated capsid stabilization in the host cell cytoplasmAlberto De Iaco, Federico Santoni, Anne Vannier, et al.
Plos Pathogens|September 5, 2009
HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradationBastien Mangeat, Gustavo Gers-Huber, Martin Lehmann, et al.
Journal of Virology|February 14, 2003
As(2)O(3) enhances retroviral reverse transcription and counteracts Ref1 antiviral activityLionel Berthoux, Greg J Towers, Cagan Gurer, et al.
Pageof 16

Showing results (41-50 of 152) with videos related to

Sort By:
Pageof 16
Molecular Biology of the Cell|February 10, 2004
HIV-1 Vpr induces defects in mitosis, cytokinesis, nuclear structure, and centrosomesFred Chang, Fabio Re, Sarah Sebastian, et al.
The Journal of Infectious Diseases|October 24, 2013
Overcoming current limitations in humanized mouse researchMichael A Brehm, Leonard D Shultz, Jeremy Luban, et al.
The Journal of Biological Chemistry|July 9, 2009
The double-stranded RNA binding domain of the vaccinia virus E3L protein inhibits both RNA- and DNA-induced activation of interferon betaJean-Baptiste Marq, Stéphane Hausmann, Jeremy Luban, et al.
Plos One|October 8, 2010
Cyclosporine A-sensitive, cyclophilin B-dependent endoplasmic reticulum-associated degradationRiccardo Bernasconi, Tatiana Soldà, Carmela Galli, et al.
The Journal of Clinical Investigation|September 17, 2005
TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ TregsBrygida Bisikirska, John Colgan, Jeremy Luban, et al.
Cell Reports|April 5, 2025
Molecular basis for the increased fusion activity of the Ebola virus glycoprotein epidemic variant A82V: Insights from simulations and experimentsNatasha D Durham, Aastha Jain, Angela Howard, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Regulation of Ebola GP conformation and membrane binding by the chemical environment of the late endosomeAastha Jain, Ramesh Govindan, Alex Berkman, et al.
Retrovirology|February 19, 2013
TNPO3 protects HIV-1 replication from CPSF6-mediated capsid stabilization in the host cell cytoplasmAlberto De Iaco, Federico Santoni, Anne Vannier, et al.
Plos Pathogens|September 5, 2009
HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradationBastien Mangeat, Gustavo Gers-Huber, Martin Lehmann, et al.
Journal of Virology|February 14, 2003
As(2)O(3) enhances retroviral reverse transcription and counteracts Ref1 antiviral activityLionel Berthoux, Greg J Towers, Cagan Gurer, et al.
Pageof 16